{"id":"W2154006657","doi":"10.1634/theoncologist.10-9-760","title":"Nimotuzumab: Evidence of Clinical Benefit Without Rash","year":2005,"lang":"en","type":"letter","venue":"The Oncologist","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rash; Nimotuzumab; Dermatology; Pharmacology; Oncology; Intensive care medicine; Internal medicine; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001689354,0.0003890633,0.001510055,0.00024227,0.0002300007,0.000655662,0.0004276861,0.001010129,0.01618191],"category_scores_gemma":[0.003886994,0.0001107321,0.0004961317,0.0003822077,0.0004225766,0.0005227298,0.0002376414,0.001646727,0.002944124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006696085,"about_ca_system_score_gemma":0.0005179032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001804449,"about_ca_topic_score_gemma":0.0006851752,"domain_scores_codex":[0.9992979,0.0003743593,0.0000493393,0.00006959091,0.0001657283,0.00004310552],"domain_scores_gemma":[0.9983265,0.0009217238,0.0002365673,0.00008818688,0.0001527437,0.0002743046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05861572,0.000914393,0.004417874,0.005449785,0.00111971,0.002092007,0.00007751133,0.000455789,0.01255538,0.004354825,0.1043547,0.8055924],"study_design_scores_gemma":[0.08087306,0.05125726,0.04680753,0.002813596,0.002578766,0.0123211,0.0001375144,0.001396072,0.01298412,0.008563293,0.7801874,0.00008025631],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"commentary","genre_scores_codex":[0.2198945,0.4462407,0.00367312,0.06595781,0.008063592,0.001245979,0.004308559,0.0006384502,0.2499773],"genre_scores_gemma":[0.7810729,0.1176072,0.003012545,0.05249056,0.007437662,0.0004091443,0.003513799,0.0001271965,0.03432909],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.01618191,"threshold_uncertainty_score":0.05413389,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2365291259437567,"score_gpt":0.4906644354273119,"score_spread":0.2541353094835552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}